Back to search

Article

Effect of Systemic Teriparatide (PTH1-34) versus Placebo on Bone MineralDensity (BMD) after Lumbar Spinal Arthrodesis: A Secondary Analysis of aRandomized Clinical Trial

2022-11-15

Abstract excerpt

<h4>Background: </h4> The present study is a secondary analysis of data from a randomized, double-blind, placebo controlled clinical trial. Patients undergoing decompression and non-instrumented lumbar arthrodesis may have initial bone loss after surgery, increasing their fracture risk. The aim of this analysis is to determine whether short term systemic Teriparatide has a beneficial effect on Bone Mineral Density...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0fb9b1b6-aca1-5dce-82c9-f69a50bb1d2e
DOI
10.21203/rs.3.rs-2234021/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effect of Systemic Teriparatide (PTH1-34) versus Placebo on Bone MineralDensity (BMD) after Lumbar Spinal Arthrodesis: A Secondary Analysis of aRandomized Clinical TrialDOI 10.21203/rs.3.rs-2234021/v1
Select a neighboring publication to make it the new centre.